Yersinia virulence factor YopJ acts as a deubiquitinase to inhibit NF-κB activation

203Citations
Citations of this article
130Readers
Mendeley users who have this article in their library.
Get full text

Abstract

The bacterial pathogens of the genus Yersinia, the causative agents of plague, septicemia, and gastrointestinal syndromes, use a type III secretion system to inject virulence factors into host target cells. One virulence factor, YopJ, is essential for the death of infected macrophages and can block host proinflammatory responses by inhibiting both the nuclear factor κB (NF-κB) and mitogen-activated protein kinase pathways, which might be important for evasion of the host immune response and aid in establishing a systemic infection. Here, we show that YopJ is a promiscuous deubiquitinating enzyme that negatively regulates signaling by removing ubiquitin moieties from critical proteins, such as TRAF2, TRAF6, and IκBα. In contrast to the cylindromatosis tumor suppressor CYLD, which attenuates NF-κB signaling by selectively removing K63-linked polyubiquitin chains that activate IκB kinase, YopJ also cleaves K48-linked chains and thereby inhibits proteasomal degradation of IκBα. YopJ, but not a catalytically inactive YopJ mutant, promoted deubiquitination of cellular proteins and cleaved both K48- and K63-linked polyubiquitin. Moreover, an in vitro assay was established to demonstrate directly the deubiquitinating activity of purified YopJ. JEM © The Rockefeller University Press.

Cite

CITATION STYLE

APA

Zhou, H., Monack, D. M., Kayagaki, N., Wertz, I., Yin, J., Wolf, B., & Dixit, V. M. (2005). Yersinia virulence factor YopJ acts as a deubiquitinase to inhibit NF-κB activation. Journal of Experimental Medicine, 202(10), 1327–1332. https://doi.org/10.1084/jem.20051194

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free